FDA Inspection 625989 — Carter BloodCare - Tyler

Carter BloodCare - Tyler — FEI 1672331

The FDA completed an inspection of Carter BloodCare - Tyler on October 20, 2009 in Tyler, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 20, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tyler, TX (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
6121 CFR 606.60(a)Provide proper equipment to meet requirements
9821 CFR 606.100(c)Thorough investigations